Synthesis and Procurement of PPARγ Ligands

Rosiglitazone, pioglitazone, tesaglitazar, GW9662, T0070907, UVI3003 and SR1664 were purchased from Tocris Bioscience (Minneapolis, MN). SR2595 and SR10221 were synthesized according to published methods (25 (link)). GW1929, BADGE (Bisphenol A diglycidyl ether), SR202 and GW6471 were purchased from Sigma-Aldrich (St. Louis, MO).

Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link: Access Free Full Text.

Goldstein J.T., Berger A.C., Shih J., Duke F.F., Furst L., Kwiatkowski D.J., Cherniack A.D., Meyerson M, & Strathdee C.A. (2017). Genomic activation of PPARG reveals a candidate therapeutic axis in bladder cancer. Cancer research, 77(24), 6987-6998.

Publication 2017

Rosiglitazone pioglitazone tesaglitazar GW9662 T0070907 UVI3003 GW1929 GW6471

Bisphenol a diglycidyl ether Gw1929 Gw6471 Gw9662 Pioglitazone Rosiglitazone Sr1664 Sr2595 T0070907 Tesaglitazar Uvi3003

Corresponding Organization : Dana-Farber Cancer Institute

Other organizations : Brigham and Women's Hospital

Top 5 similar protocols

Variable analysis

independent variables

Rosiglitazone
Pioglitazone
Tesaglitazar
GW9662
T0070907
UVI3003
SR1664
SR2595
SR10221
GW1929
BADGE (Bisphenol A diglycidyl ether)
SR202
GW6471

dependent variables

Measured outcomes

control variables

Not explicitly mentioned

positive controls

Not specified

negative controls

Not specified

Annotations

Based on most similar protocols

Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.

As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!